id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1307-0006,FDA,FDA-2020-N-1307,Reference 5 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials,Supporting & Related Material,Background Material,2020-07-14T04:00:00Z,2020,7,,,2020-07-14T16:34:48Z,,0,0,0900006484756910
FDA-2020-N-1307-0007,FDA,FDA-2020-N-1307,Reference 6 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials,Supporting & Related Material,Background Material,2020-07-14T04:00:00Z,2020,7,,,2020-07-14T16:35:58Z,,0,0,0900006484756911
FDA-2020-N-1307-0003,FDA,FDA-2020-N-1307,Reference 1 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials,Supporting & Related Material,Background Material,2020-07-14T04:00:00Z,2020,7,,,2020-07-14T16:24:56Z,,0,0,09000064847560aa
FDA-2020-N-1307-0004,FDA,FDA-2020-N-1307,Reference 2 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials,Supporting & Related Material,Background Material,2020-07-14T04:00:00Z,2020,7,,,2020-07-14T16:30:10Z,,0,0,09000064847560ab
FDA-2020-N-1307-0008,FDA,FDA-2020-N-1307,Reference 4 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials,Supporting & Related Material,Background Material,2020-07-14T04:00:00Z,2020,7,,,2020-07-14T16:43:31Z,,0,0,090000648475690f
FDA-2020-N-1307-0005,FDA,FDA-2020-N-1307,Reference 3 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials,Supporting & Related Material,Background Material,2020-07-14T04:00:00Z,2020,7,,,2020-07-14T16:29:47Z,,0,0,09000064847560ac
FDA-2020-N-1307-0001,FDA,FDA-2020-N-1307,Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials,Notice,60 Day Proposed Information Collection,2020-07-07T04:00:00Z,2020,7,2020-07-07T04:00:00Z,2020-09-09T03:59:59Z,2020-09-09T01:02:15Z,2020-14514,0,0,090000648472b55c